IL70881A - 3-(5-aminopentyl)-amino-1-benzazepin-2-one-1-alkanoic acid derivatives,process for their preparation and pharmaceutical compositions containing them - Google Patents

3-(5-aminopentyl)-amino-1-benzazepin-2-one-1-alkanoic acid derivatives,process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL70881A
IL70881A IL70881A IL7088184A IL70881A IL 70881 A IL70881 A IL 70881A IL 70881 A IL70881 A IL 70881A IL 7088184 A IL7088184 A IL 7088184A IL 70881 A IL70881 A IL 70881A
Authority
IL
Israel
Prior art keywords
benzazepin
aminopentyl
amino
preparation
pharmaceutical compositions
Prior art date
Application number
IL70881A
Other languages
English (en)
Other versions
IL70881A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL70881A0 publication Critical patent/IL70881A0/xx
Publication of IL70881A publication Critical patent/IL70881A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL70881A 1983-02-10 1984-02-07 3-(5-aminopentyl)-amino-1-benzazepin-2-one-1-alkanoic acid derivatives,process for their preparation and pharmaceutical compositions containing them IL70881A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/465,695 US4473575A (en) 1982-07-19 1983-02-10 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids

Publications (2)

Publication Number Publication Date
IL70881A0 IL70881A0 (en) 1984-05-31
IL70881A true IL70881A (en) 1987-10-30

Family

ID=23848805

Family Applications (1)

Application Number Title Priority Date Filing Date
IL70881A IL70881A (en) 1983-02-10 1984-02-07 3-(5-aminopentyl)-amino-1-benzazepin-2-one-1-alkanoic acid derivatives,process for their preparation and pharmaceutical compositions containing them

Country Status (24)

Country Link
US (1) US4473575A (fr)
EP (2) EP0119954B1 (fr)
JP (2) JPS59172473A (fr)
KR (1) KR900009023B1 (fr)
AR (8) AR242564A1 (fr)
AT (2) ATE48598T1 (fr)
AU (1) AU574061B2 (fr)
CA (2) CA1225397A (fr)
CY (1) CY1674A (fr)
DD (1) DD218359A5 (fr)
DE (2) DE3480705D1 (fr)
DK (2) DK58184A (fr)
ES (10) ES8609261A1 (fr)
FI (1) FI77857C (fr)
GR (1) GR79809B (fr)
HK (1) HK97592A (fr)
HU (1) HU192394B (fr)
IE (1) IE56858B1 (fr)
IL (1) IL70881A (fr)
NO (1) NO166232C (fr)
NZ (1) NZ207091A (fr)
PT (1) PT78075B (fr)
SG (1) SG94992G (fr)
ZA (1) ZA84958B (fr)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
US4537885A (en) * 1983-02-10 1985-08-27 Ciba Geigy Corporation Certain benzazocinone and benzazoninone derivatives
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4600534A (en) * 1984-02-06 1986-07-15 Ciba-Geigy Corporation Process and intermediates for manufacture of 3-(5-amino-1-carboxypentylamino)-tetrahydro-1-benzazepin-2-one-1-acetic acid
EP0166357A3 (fr) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzo-lactames condensés et leurs compositions pharmaceutiques
DE3586445T2 (de) * 1984-06-26 1993-01-14 Merck & Co Inc Kondensierte benzo-laktam-verbindungen und deren pharmazeutische zusammensetzungen.
US4692522A (en) * 1985-04-01 1987-09-08 Merck & Co., Inc. Benzofused lactams useful as cholecystokinin antagonists
US4785089A (en) * 1985-06-13 1988-11-15 Ciba-Geigy Corporation Novel sulfonic acid esters and their preparation
DE3767514D1 (de) * 1986-03-11 1991-02-28 Thompson Barry Antony Fuettern von vieh mit polymeren.
AT399717B (de) * 1986-05-28 1995-07-25 Ciba Geigy Ag Verfahren zur herstellung von (2,5-dihydro-2-oxo- 5-phenyl-3-furanyl)aminen
GR870819B (en) * 1986-05-28 1987-09-25 Ciba Geigy Ag Preparation method of (2,5 dihydro -2 -oxo-5 - phenyl -3 - furanyl) amines and their utilization for preparing ace - inhibitors
US5028704A (en) * 1986-05-28 1991-07-02 Ciba-Geigy Corporation (2,5-dihydro 5-phenyl-2-oxo-3-furanyl)amines, methods of manufacture, and use thereof in the production of angiotensin converting enzyme inhibitors
US4918187A (en) * 1986-05-28 1990-04-17 Ciba-Geigy Corporation [2,5-Dihydro 5-phenyl-2-oxo-3-furanyl]amines
US4962105A (en) * 1987-10-19 1990-10-09 Ciba-Geigy Corporation Potentiation of antihypertensive effect of ace inhibitors
JPH07116224B2 (ja) * 1987-12-29 1995-12-13 吉富製薬株式会社 ベンゾラクタム化合物
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
US5552397A (en) * 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
US5646276A (en) * 1992-05-13 1997-07-08 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
RU2124503C1 (ru) 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
GB9212308D0 (en) * 1992-06-10 1992-07-22 Ici Plc Therapeutic compositions
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
WO1995014671A1 (fr) * 1993-11-22 1995-06-01 Merck & Co., Inc. 3-acylaminobenzazepines
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
CZ285008B6 (cs) * 1994-08-18 1999-04-14 Merck & Co., Inc. 2,3-dihydro-1-(2,2,2-trifluorethyl)-2-oxo-5-fenyl-1H-1,4-benzodiazepinové deriváty a farmaceutický prostředek s jejich obsahem
US5587375A (en) * 1995-02-17 1996-12-24 Bristol-Myers Squibb Company Azepinone compounds useful in the inhibition of ACE and NEP
US5877313A (en) 1995-05-17 1999-03-02 Bristol-Myers Squibb Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
US5726171A (en) * 1995-06-07 1998-03-10 Merck & Co Inc N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
ES2193241T3 (es) * 1995-06-07 2003-11-01 Merck & Co Inc Nuevas n-2-oxo2.3.4.5-tetrajodrp-1h-1,5-benzodiazepin-3-il)-3-amidas.
US5631251A (en) * 1995-06-07 1997-05-20 Merck & Co., Inc. 5-cyclopropyl-1,4 benzodiazepine-2-ones
US5635504A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
US5700797A (en) * 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
US5650408A (en) * 1995-06-07 1997-07-22 Karanewsky; Donald S. Thiazolo benzazepine containing dual action inhibitors
US6211235B1 (en) 1996-11-22 2001-04-03 Elan Pharmaceuticals, Inc. Compounds for inhibiting β-amyloid peptide release and/or its synthesis
US6191166B1 (en) * 1997-11-21 2001-02-20 Elan Pharmaceuticals, Inc. Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
WO1998041510A1 (fr) * 1997-03-14 1998-09-24 Shionogi & Co., Ltd. Nouveaux derives du benzolactame et compositions medicamenteuses les contenant
US6528505B1 (en) 1998-06-22 2003-03-04 Elan Pharmaceuticals, Inc. Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6552013B1 (en) 1998-06-22 2003-04-22 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6509331B1 (en) 1998-06-22 2003-01-21 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6569851B1 (en) * 1998-06-22 2003-05-27 Elan Pharmaceutials, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6774125B2 (en) * 1998-06-22 2004-08-10 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
WO2001035964A1 (fr) * 1999-11-18 2001-05-25 Antexpharma, Inc. 1-benzazepines substituees et leurs derives
US7795468B2 (en) * 2001-01-19 2010-09-14 Chevron U.S.A. Inc. Functionalized higher diamondoids
AU2002348276A1 (en) * 2001-11-16 2003-06-10 Bristol-Myers Squibb Company Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
US20050192265A1 (en) * 2003-03-20 2005-09-01 Thompson Richard C. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
US20050203168A1 (en) * 2004-03-11 2005-09-15 The Regents Of The University Of Michigan Angiotensin converting enzyme inhibitor use for treatment and prevention of gastrointestinal disorders
US8080579B2 (en) * 2005-10-03 2011-12-20 The Regents Of The University Of Michigan Compositions and methods for treatment of inflammatory bowel disease
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US20070238770A1 (en) * 2006-04-05 2007-10-11 Bristol-Myers Squibb Company Process for preparing novel crystalline forms of peliglitazar, novel stable forms produced therein and formulations
WO2008057862A2 (fr) 2006-11-01 2008-05-15 Bristol-Myers Squibb Company Modulateurs de récepteur de glucocorticoïde, d'activité ap-1 et/ou nf-κb, et leur utilisation
CN101573340A (zh) 2006-11-01 2009-11-04 百时美施贵宝公司 糖皮质激素受体AP-1和/或NF-κB活性的调节剂及其用途
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
US7828840B2 (en) * 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
EP2810951B1 (fr) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
WO2009158380A1 (fr) 2008-06-24 2009-12-30 Bristol-Myers Squibb Company Modulateurs de cyclopentathiopène du récepteur glucocorticoïde, ap-1, et/ou activité nf-kappa b et utilisation de ceux-ci
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions utiles pour le traitement de troubles gastro-intestinaux
CA2905438A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
PT3004138T (pt) 2013-06-05 2024-06-18 Bausch Health Ireland Ltd Agonistas ultrapuros de guanilato ciclase c, método de produção e utilização dos mesmos
WO2015027021A1 (fr) 2013-08-22 2015-02-26 Bristol-Myers Squibb Company Dérivés imide et acylurée utilisés comme modulateurs du récepteur de glucocorticoïdes

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330823A (en) * 1964-12-16 1967-07-11 Squibb & Sons Inc N-amino-loweralkylene-benzo-lactams
US3395150A (en) * 1965-02-26 1968-07-30 Squibb & Sons Inc Benzothiazepine carboxamides and derivatives thereof
GB1305278A (fr) * 1970-03-12 1973-01-31
JPS5129522B2 (fr) * 1972-07-13 1976-08-26
JPS5520970B2 (fr) * 1972-07-15 1980-06-06
FR2358151A1 (fr) * 1976-03-31 1978-02-10 Roussel Uclaf Nouvelles benzazepines et leurs sels, procede de preparation et application a titre de medicaments
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4377515A (en) * 1979-10-01 1983-03-22 Merck & Co., Inc. Long lasting agonists and antagonists of LH-RH
GR74635B (fr) * 1980-08-18 1984-06-29 Merck & Co Inc
US4409146A (en) * 1980-10-06 1983-10-11 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
IN156096B (fr) * 1981-03-19 1985-05-11 Usv Pharma Corp
US4415496A (en) * 1981-03-23 1983-11-15 Merck & Co., Inc. Bicyclic lactams
ZA825779B (en) * 1981-08-11 1984-04-25 Ciba Geigy Ag Benzazepins-2-ones
CY1403A (en) * 1981-08-11 1987-12-18 Ciba Geigy Ag Benzazepin-2-ones
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
DE3373469D1 (en) * 1982-09-30 1987-10-15 Merck & Co Inc 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents

Also Published As

Publication number Publication date
KR840007722A (ko) 1984-12-10
EP0119954B1 (fr) 1990-03-14
ES8609264A1 (es) 1986-09-01
CA1218993A (fr) 1987-03-10
IE56858B1 (en) 1992-01-01
FI77857C (fi) 1989-05-10
ES544256A0 (es) 1987-05-01
DD218359A5 (de) 1985-02-06
EP0119954A3 (en) 1986-06-11
AR243165A1 (es) 1993-07-30
ES8609261A1 (es) 1986-07-16
ES544258A0 (es) 1986-09-01
ZA84958B (en) 1984-09-26
AR242190A1 (es) 1993-03-31
GR79809B (fr) 1984-10-31
AR243162A1 (es) 1993-07-30
IE840302L (en) 1984-08-10
ES8707216A1 (es) 1987-07-16
NO166232C (no) 1991-06-19
AU574061B2 (en) 1988-06-30
NO840487L (no) 1984-08-13
EP0119955B1 (fr) 1989-12-13
AR243161A1 (es) 1993-07-30
JPH0460108B2 (fr) 1992-09-25
ES544255A0 (es) 1986-09-01
JPH0421665B2 (fr) 1992-04-13
NZ207091A (en) 1985-11-08
FI840513A0 (fi) 1984-02-08
FI840513A (fi) 1984-08-11
ES8703859A1 (es) 1987-03-01
EP0119955A2 (fr) 1984-09-26
ES544127A0 (es) 1987-01-01
CY1674A (en) 1993-10-10
ES8702363A1 (es) 1987-01-01
HK97592A (en) 1992-12-11
HU192394B (en) 1987-06-29
ES529594A0 (es) 1986-07-16
EP0119954A2 (fr) 1984-09-26
AR243163A1 (es) 1993-07-30
ES544259A0 (es) 1986-10-16
ES8700239A1 (es) 1986-10-16
JPS59172473A (ja) 1984-09-29
ES8705409A1 (es) 1987-05-01
ES8609262A1 (es) 1986-09-01
DE3481612D1 (de) 1990-04-19
ES544260A0 (es) 1986-09-01
DK171257B1 (da) 1996-08-12
KR900009023B1 (ko) 1990-12-17
IL70881A0 (en) 1984-05-31
ES544254A0 (es) 1987-03-01
ES8609263A1 (es) 1986-09-01
DK58184A (da) 1984-08-11
NO166232B (no) 1991-03-11
ES529595A0 (es) 1987-07-16
ATE50989T1 (de) 1990-03-15
DE3480705D1 (de) 1990-01-18
DK58284A (da) 1984-08-11
PT78075B (en) 1986-06-11
AU2443084A (en) 1984-08-16
CA1225397A (fr) 1987-08-11
JPS59172475A (ja) 1984-09-29
DK58184D0 (da) 1984-02-09
ES8609265A1 (es) 1986-09-01
US4473575A (en) 1984-09-25
ES544257A0 (es) 1986-09-01
FI77857B (fi) 1989-01-31
AR242564A1 (es) 1993-04-30
SG94992G (en) 1992-12-04
DK58284D0 (da) 1984-02-09
AR243164A1 (es) 1993-07-30
ATE48598T1 (de) 1989-12-15
EP0119955A3 (en) 1986-06-11
AR242191A1 (es) 1993-03-31
PT78075A (en) 1984-03-01

Similar Documents

Publication Publication Date Title
IL70881A (en) 3-(5-aminopentyl)-amino-1-benzazepin-2-one-1-alkanoic acid derivatives,process for their preparation and pharmaceutical compositions containing them
IL69347A (en) Methylene-diphosphonic acid derivatives,their preparation and pharmaceutical compositions containing them
IL69601A0 (en) Naphthyridine-,quinoline-and benzoxazine-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
DE3461090D1 (en) 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them
DE3263633D1 (en) Imidazodiazepines, process for their preparation and pharmaceutical compositions containing them
HUT37424A (en) Process for preparing new 5-pyridyl-1,3-thiazoie derivatives and pharmaceutical compositions containing thereof as active substances
IL72021A (en) Angiotensinase inhibiting 3-(mercaptoalkyl)-2-oxo-1-pyrrolidine-acetic acid derivatives,their preparation and pharmaceutical compositions containing them
ZA859035B (en) Amino-salicylic acid derivatives,salts thereof,process for their preparation and pharmaceutical compositions containing them
ZA849499B (en) Indole derivatives,processes for their preparation and pharmaceutical compositions containing them
IL63428A (en) 2-pyridyl thiazoline-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL68323A0 (en) Phenoxyalkylcarboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
EP0145121A3 (en) Pyrazoloquinolines, process for their preparation, and pharmaceutical compositions containing them
GR3001416T3 (en) Substituted amino-dihydrooxazoles, -thiazoles and -imidazoles, process for their preparation and pharmaceutical compositions containing them
DE3161238D1 (en) 20-deoxyrosaramicin derivatives, process for their preparation and pharmaceutical compositions containing them
IL87856A0 (en) Alkadiene derivatives,process for their preparation and pharmaceutical compositions containing them
IL69735A (en) 1-phenyl-1-aminoalkyl-cyclobutane derivatives,process for their preparation and pharmaceutical compositions containing them
IL84791A0 (en) Substituted aminopropionamides,process for their preparation and pharmaceutical compositions containing them
GB2138817B (en) 4-pheny-tetrahydro-furano-pyridines, process for their preparation, and pharmaceutical compositions containing them
DE3380875D1 (en) Piperidine-3-carboxylic acid derivatives, process for their preparation, and pharmaceutical compositions containing them
IL64123A (en) Biphenylyloxypropoxypyrimidine derivatives,process for their preparation and pharmaceutical compositions containing them
IL82332A (en) Substituted 2-phenylbenzothiazin(-3-)one derivatives,process for their preparation and pharmaceutical compositions containing them
ZA837081B (en) Piperidine derivatives,processes for their preparation and pharmaceutical compositions containing them
IL82333A (en) Substituted 2-phenylbenzothiazin-3-one derivatives,process for their preparation and pharmaceutical compositions containing them
ZA841781B (en) Penim compounds,methods for their preparation and pharmaceutical compositions containing them
IL81978A (en) Indenopyrimidine derivatives,process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
RH Patent void